FDA Drug recall D-0769-2026
Kian Pee Wan Capsules, 30-count bottles
- FDA Drug
- Class I
- ongoing
- Published 2026-08-19
On 2026-08-19 the FDA classified a Class I recall of Kian Pee Wan Capsules, 30-count bottles by Buy Herbal, citing marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0769-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2026-03-21 |
| Published | 2026-08-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Buy Herbal |
| Distribution | n/a |
Product
Kian Pee Wan Capsules, 30-count bottles
Reason
Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Identifiers
| code_info | All lots within expiry. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0769-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.